94298 ⎘
Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals
Sub-classes:METHODS FOR TREATING CANCER
#2SODIUM-HYDROGEN EXCHANGER 3 INHIBITOR COMPOUNDS
#3MASP-2 INHIBITORS AND METHODS OF USE
#4MASP-2 INHIBITORS AND METHODS OF USE
#5COMPOUNDS AND METHODS FOR INHIBITING NHE-MEDIATED ANTIPORT IN THE TREATMENT OF DISORDERS ASSOCIATED WITH FLUID RETENTION OR SALT OVERLOAD AND GASTROINTESTINAL TRACT DISORDERS
#6MASP-2 INHIBITORS AND METHODS OF USE
#7COMPOUNDS AND METHODS FOR INHIBITING NHE-MEDIATED ANTIPORT IN THE TREATMENT OF DISORDERS ASSOCIATED WITH FLUID RETENTION OR SALT OVERLOAD AND GASTROINTESTINAL TRACT DISORDERS
#8COMPOUNDS AND METHODS OF USE
#9N-HETEROARYLALKYL-2-(HETEROCYCLYL AND HETEROCYCLYLMETHYL) ACETAMIDE DERIVATIVES AS SSTR4 AGONISTS
#10MASP-2 inhibitors and methods of use
#11PROGRANULIN MODULATORS AND METHODS OF USING THE SAME
#12COMPOUNDS AND METHODS OF USE
#13Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
#14SMALL MOLECULES POLYMERASE INHIBITORS
#15Combination pharmaceutical agents as RSV inhibitors
#16THIOSEMICARBAZONE COMPOUNDS AND USES THEREOF
#17SODIUM-HYDROGEN EXCHANGER 3 INHIBITOR COMPOUNDS
#18SUMO INHIBITOR COMPOUNDS AND USES THEREOF
#19Process for the halogenation at the alpha-h position of alkylarenes variously substituted on the aromatic ring
#20PROGRANULIN MODULATORS AND METHODS OF USING THE SAME
#21Opioid receptor modulators and products and methods related thereto
#22OPIOID RECEPTOR MODULATORS AND PRODUCTS AND METHODS RELATED THERETO
#23Manganese-based chelate conjugates for molecular MR imaging
#24Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
#253′ end caps for RNAi agents for use in RNA interference
#26MASP-2 inhibitors and methods of use
#27Compounds and methods of use
#28Combination pharmaceutical agents as RSV inhibitors
#29Tetrahydroisoquinolines for use as MOR/NOP dual agonists
#30Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
#31Use of substituted dihydroisoquinolinium salts for treating keratin materials, compositions and implementation processes
#32Manganese-based chelate conjugates for molecular MR imaging
#33Piperidine derivative and preparation method and pharmaceutical use thereof
#34Condensed ring derivative, and preparation method, intermediate, pharmaceutical composition and use thereof
#35Necrosis inhibitors
#36Method for the production of praziquantel and precursors thereof
#37Condensed ring derivative, and preparation method, intermediate, pharmaceutical composition and use thereof
#38Method for the production of Praziquantel and precursors thereof
#39Inhibitors of the fibroblast growth factor receptor
#40Heterocyclic compounds and their use as retinoid-related orphan receptor (ROR) gamma-T inhibitors
#41Polycyclic compound and organic electronic device comprising the same
#423′end caps for RNAi agents for use in RNA interference
#43Heterocyclic compound
#44Heterocyclic compound
#45Heterocyclic compound
#46Method for producing novel organometallic complex and amine compound
#47Isoquinoline derivatives
#48Method for producing 3,4-dihydroisoquinoline derivatives and production intermediates of same
#49Heterocyclic compound
#50Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin
#51Inhibitors of the fibroblast growth factor receptor
#52Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorder
#53Aryl, heteroaryl, and heterocycle substituted tetrahydroisoquinolines and use thereof
#543-aryl-5-substituted-isoquinolin-1-one compounds and their therapeutic use
#55TRPA1 antagonists
#56Method for preparing (R)-praziquantel
#57Method for preparing (R)-praziquantel
#58Estrogen receptor ligands
#59Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin
#60Polycyclic compound and organic electronic device comprising the same
#61Sulfonamide compounds useful as CYP17 inhibitors
#62N- (2 -AMINOPHENYL) BENZAMIDE DERIVATIVES AS HISTONE DEACETYLASE INHIBITORS
#63Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
#64Phenyl-tetrahydroisoquinoline derivatives
#65Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
#66Naphthalene derivative
#67Cannabinoid receptor modulators
#68Antimicrobial agents
#69Transglutaminase TG2 inhibitors, pharmaceutical compositions, and methods of use thereof
#70Acetylenic heteroaryl compounds
#71Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin
#72Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
#73Wnt pathway antagonists
#74Nitrile derivatives and their pharmaceutical use and compositions
#75Nitrogenous-ring acylguanidine derivative
#76Small molecule CD4 mimetics and uses thereof
#77ARYL SULFONAMIDES
#78INHIBITORS OF BACTERIAL PLASMINOGEN ACTIVATORS
#79Cyclic compound having substituted phenyl group
#80N-acyl anthranilic acid derivative or salt thereof
#81DERIVATIVES OF HETEROARYL-ALKYLCARBAMATES, METHODS FOR THEIR PREPARATION AND USE THEREOF AS FATTY ACID AMIDO HYDROLASE ENZYME INHIBITORS
#82ARYL SULFONAMIDES
#83Bicyclic-substituted amines as histamine-3 receptor ligands
#84PIPERAZINYL OXOALKYL TETRAHYDROISOQUINOLINES AND RELATED ANALOGUES
#85MODULATORS OF THE HISTAMINE H3 RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO
#86Aryl, heteroaryl, and heterocycle substituted tetrahydroisoquinolines and use thereof
#87Amine derivative having NPY Y5 receptor antagonistic activity
#881-substituted tetrahydroisoquinoline compound
#89Bridged six-membered ring compounds
#90Tetrahydroisoquinoline compound
#91DERIVATIVES OF HETEROARYL-ALKYLCARBAMATES, METHODS FOR THEIR PREPARATION AND USE THEREOF AS FATTY ACID AMIDO HYDROLASE ENZYME INHIBITORS
#92Amine derivative having NPY Y5 receptor antagonistic activity
#93TYROSINE DERIVATIVE
#94NOVEL ANTIOXIDANTS AND METHODS OF TREATMENT
#95SUBSTITUTE ISOQUINOLINES USEFUL IN THE TREATMENT OF DISEASES SUCH AS CANCER AND ATHEROSCLEROSIS
#96Tetrahydro isoquinoline derivatives, preparation methods and medicinal uses thereof
#97TRPA1 antagonists
#98Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin
#99Acetylenic heteroaryl compounds
#100Technetium- and rhenium-bis(heteroaryl) complexes, and methods of use thereof
#101Metal complexes
#102Isoquinolines as IGF-1R inhibitors
#103Bicyclic-substituted amines as histamine-3 receptor ligands
#104Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin
#105METHOD FOR RESOLVING ENANTIOMERS FROM RACEMIC MIXTURE HAVING CHIRAL CARBON IN ALPHA POSITION OF NITROGEN
#106Diaryl-substituted tetrahydroisoquinolines as histamine Hreceptor and serotonin transporter modulators
#107Synthesis of amino-protected cyclohexane-1,4-diyldimethanamine and its derivatives
#108Piperazines as antimalarial agents
#109Substituted 4-phenyltetrahydroisoquinolines, process for their preparation, pharmaceutical compositions and therapeutic use
#110Dpp-IV Inhibitors
#111Aryl sulfonamides
#112Derivatives of 4-(n-azacycloalkyl) anilides as potassium channel modulators
#113Anthracene derivative and organic electroluminescent element using the same
#114Technetium- and rhenium-bis (heteroaryl) complexes, and methods of use thereof
#115Dpp-IV Inhibitors
#116Substituted piperazines and methods of use
#1171-aryl-4-substituted isoquinolines
#118Piperazinyl oxoalkyl tetrahydroisoquinolines and related analogues
#119CETP inhibitors
#120Substituted 4-phenyltetrahydroisoquinolines, pharmaceutical compositions thereof, methods for their preparation and therapeutic use
#121Organometallic Complex, Luminescent Solid, Organic el Element and Organic el Display
#122Anthracene derivative and organic electronic device using the same
#123SUBSTITUTED TETRAHYDROISOQUINOLINES USED IN THE FORM OF MMP INHIBITORS, METHOD FOR THE PRODUCTION AND USE THEREOF IN THE FORM OF DRUGS
#124Dpp-iv inhibitors
#125Tetrahydroisoquinoline-and tetrahydrobenzazepine derivatives as igf-1 r inhibitors
#126High affinity small molecule C5a receptor modulators
#127Derivatives of heteroaryl-alkylcarbamates, methods for their preparation and use thereof as fatty acid amido hydrolase enzyme inhibitors
#128Isoquinoline potassium channel inhibitors
#129Tetrahydroisoquinoline compounds
#130Bicyclic-substituted amines as histamine-3 receptor ligands
#131Immunomodulation with novel pharmaceutical compositions
#132Thiocarbamate inhibitors of alpha-4 integrins
#133Use of aryl- and heteroaryl-substituted tetrahydroisoquinolines to block reuptake of norepinephrine, dopamine, and serotonin
#134Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin
#135Heterocyclic anti-epileptogenic agents and methods of use thereof
#136Guanidino compounds
#137Selective estrogen receptor-β ligands
#138Inhibitors of dipeptidyl peptidase iv
#139Optical data carrier comprising a cyanine dye as light-absorbent compound in the information layer